Literature DB >> 18792484

Lipids in association with serum magnesium in diabetes mellitus patients.

Hamid Nasri1, Hamid-Reza Baradaran.   

Abstract

AIM: To investigate whether and how serum Magnesium (Mg) concentrations influence the serum lipids in diabetes mellitus (DM) patients. The cross-sectional study was conducted on diabetic mellitus (DM) patients with various kidney functions not yet on dialysis. PATIENTS AND METHODS: Serum lipoprotein(a), glycosilated hemoglobin (HbA1c), serum magnesium (Mg), serum creatinine (creat), serum lipids consisting of triglycerids (Tg), cholesterol (Chol), high-density lipoprotein (HDL) were measured.
RESULTS: Study patients included 122 patients (82F, 40M). The mean patients' age was 63 (+/- 10) years. The mean length of time they were diabetic was 7.4 (+/- 5.8) years (median: 6 years). The mean serum Mg was 2 (+/- 0.4) mg/dl (median: 1.99 mg/dl). The mean creatinine clearance was 64 (+/- 24) cc/min (median: 64 cc/min). In this study significant inverse correlations of serum Mg with serum cholesterol and LDL as well as nonsignificant correlations of serum Mg with serum Lp(a), HDL, Tg and with serum HgbA1c were seen. More over a significant inverse correlation of serum Mg with ages of the patients and a significant positive correlation of serum Mg with serum creatinine were seen too.
CONCLUSIONS: It seems that in diabetic patients, kidney function is a key role in the regulation of serum Lp(a) levels instead of other factors like serum Mg level. Our finding further supports the importance of Mg supplementation in diabetes mellitus patients. In our study no significant correlation between serum Mg with serum HDL and Tg were found, which needs further investigation (Tab. 1, Fig. 4, Ref. 53).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18792484

Source DB:  PubMed          Journal:  Bratisl Lek Listy        ISSN: 0006-9248            Impact factor:   1.278


  9 in total

1.  Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues.

Authors:  Azar Baradaran
Journal:  J Nephropathol       Date:  2012-10-01

2.  Evaluation of Circulating Plasma VEGF-A, ET-1 and Magnesium Levels as the Predictive Markers for Proliferative Diabetic Retinopathy.

Authors:  Gopal Niranjan; A R Srinivasan; K Srikanth; Gowda Pruthu; R Reeta; Ramasamy Ramesh; Rajendiran Anitha; V Mohana Valli
Journal:  Indian J Clin Biochem       Date:  2018-05-03

3.  Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study.

Authors:  Jui-Hua Huang; Yi-Fa Lu; Fu-Chou Cheng; John Ning-Yuean Lee; Leih-Ching Tsai
Journal:  Nutr J       Date:  2012-06-13       Impact factor: 3.271

4.  Is hypomagnesaemia a coronary risk factor among Indians with coronary artery disease?

Authors:  Namita Mahalle; Mohan V Kulkarni; Sadanand S Naik
Journal:  J Cardiovasc Dis Res       Date:  2012-10

5.  Relationship between the concentrations of heavy metals and bioelements in aging men with metabolic syndrome.

Authors:  Iwona Rotter; Danuta Kosik-Bogacka; Barbara Dołęgowska; Krzysztof Safranow; Anna Lubkowska; Maria Laszczyńska
Journal:  Int J Environ Res Public Health       Date:  2015-04-10       Impact factor: 3.390

6.  Consequences of hypomagnesemia in type 2 diabetes mellitus patients.

Authors:  Hamid Nasri
Journal:  J Renal Inj Prev       Date:  2014-12-01

7.  Magnesium and diabetes mellitus.

Authors:  Ali Ghorbani; Azar Baradaran
Journal:  J Renal Inj Prev       Date:  2012-09-01

Review 8.  Effect of magnesium supplementation on pregnancy outcome in gestational diabetes mellitus patients: A meta-analysis of randomized controlled trials.

Authors:  Qiuchan Qu; Rong Rong; Jinhua Yu
Journal:  Food Sci Nutr       Date:  2022-09-07       Impact factor: 3.553

9.  Prevention of hypomagnesemia in diabetes patients.

Authors:  Yahya Madihi; Alireza Marikhi; Hamid Nasri
Journal:  Int J Prev Med       Date:  2013-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.